COVID-19 VACCINATIONS: If, in addition to indemnity for your main employment, you would like cover for delivering COVID-19 Vaccinations please apply for our standalone extension Apply Today

Home  »   LloydsPharmacyLatest News   »   Welcome to the February 2023 PDA Update in LloydsPharmacy

Welcome to the February 2023 PDA Update in LloydsPharmacy

Keeping you informed of all the union activities within LloydsPharmacy...

Sun 19th February 2023 The PDA

In this issue :

  • Encourage all colleagues to join a trade union
  • Pay Talks Begin
  • PDA LloydsPharmacy Rep elected to PDA’s National Executive Committee
  • PJCC communications
  • International Pharmaceutical Federation (FIP)
  • Vacancies in the PDA Reps Network
  • Supporting colleagues effected by Sainsbury’s closures


We encourage you to share this newsletter with your pharmacy colleagues that are not yet members of the PDA.


thumbnail of Lloyds Newsletter February 2023

Not yet a PDA member?

If you have not yet joined the PDA, we encourage you to join today and ask your colleagues to do the same.

Membership is FREE to pharmacy students, trainee pharmacists and for the first three months of being newly qualified.


Read about our key member benefits here.




The Pharmacists' Defence Association is a company limited by guarantee. Registered in England; Company No 4746656.

The Pharmacists' Defence Association is an appointed representative in respect of insurance mediation activities only of
The Pharmacy Insurance Agency Limited which is registered in England and Wales under company number 2591975
and is authorised and regulated by the Financial Conduct Authority (Register No 307063)

The PDA Union is recognised by the Certification Officer as an independent trade union.

Cookie Use

This website uses cookies to help us provide the best user experience. If you continue browsing you are giving your consent to our use of cookies.

General Guidance Resources Surveys PDA Campaigns Regulations Locums Indemnity Arrangements Pre-Regs & Students FAQs Coronavirus (COVID-19)